We examined potential differences in the activation of MEK/ERK signaling between CD34+ and CD34- subsets of Kasumi-1 cells as well as in the BM specimens obtained from five AML patients carrying t(8:21) upon Ara-C or DNR exposure. Here, MAP2K7 is linked to acute myeloid leukemia.